The Janssen Pharmaceutical Companies of Johnson & Johnson join the International Federation of Psoriasis Associations in support of World Psoriasis Day on October 29, an annual event dedicated to raising awareness of psoriasis and psoriatic arthritis — immune diseases that affect more than 125 million people around the world.
At Janssen Immunology, we are focused on continuing to support patients by developing therapies to treat psoriasis and psoriatic arthritis, and advancing science to one day prevent, intercept and cure these diseases. We also continue to partner with organizations and advocates around the world, promoting awareness and earlier diagnosis and treatment, to address the lifelong physical, social and psychological burdens that are often associated with these diseases.
This World Psoriasis Day, we commend our partners and are proud to support efforts to bring greater understanding and recognition of psoriasis and psoriatic arthritis around the globe.
At Janssen, we collaborate with the world for the health of everyone in it.